Why insurance deals are different
Insurance is regulated mainly at the state level, and acquiring control of an insurance company generally requires approval from the insurance regulator in the insurer's home state, which in New York is the Department of Financial Services. That review looks at the buyer, its financing, and its plans, and it can take longer than the commercial negotiation. Agency and brokerage acquisitions usually do not need the same kind of approval, but producer licenses, carrier appointments, and commission arrangements must be addressed so that the business keeps running after closing. Reinsurance transactions and transfers of blocks of business raise their own regulatory and accounting questions. Knowing which kind of transaction you are in sets the timetable.
Diligence on an insurance business
For an insurer, buyers typically review loss reserves, reinsurance programs, regulatory exam reports, and complaint and market conduct history. For an agency, the focus is often on the book of business, the carrier contracts that determine who controls renewals, producer agreements and restrictive covenants, and errors and omissions claims. Sellers should gather these materials early and expect questions about any open regulatory matters. Customer data and privacy obligations also travel with the business and need attention. Problems discovered late tend to become price renegotiations or indemnity fights.
Structuring the insurance transaction
In a first meeting we ask what is being bought or sold, which states are involved, and whether any regulatory approval is required. We then discuss whether the deal should be a purchase of equity or of assets, how price adjustments and earnouts tied to client retention will work, and what protections each side needs after closing. We also look at the interim period between signing and closing, when the business must be run in the ordinary course while approvals are pending. Clear allocation of responsibility for pre-closing claims is often among the most negotiated points. With the regulatory path mapped first, the rest of the deal can be planned around it.
